Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neurotoxic Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT03293472
What this trial is testing

Neurotoxicity of Spinal Anesthesia With Ropivacaine and Bupivacaine

Who this might be right for
Anesthesia; Adverse Effect, Spinal and EpiduralAnaesthetic Complication Neurological
University of Rzeszow 60
Not applicableStudy completedNCT03213392
What this trial is testing

Enzymatic Evaluation of General Anesthetic Induced Neurotoxicity in Patients With Aneurysmal Subarachnoid Hemorrhage

Who this might be right for
Neurotoxicity
Mukilan Balu 32
Large-scale testing (Phase 3)Study completedNCT00316914
What this trial is testing

Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity Caused By Oxaliplatin in Patients Receiving Combination Chemotherapy for Stage II, Stage III, or Stage IV Colorectal Cancer That Has Been Completely Removed By Surgery

Who this might be right for
Colorectal CancerNeurotoxicity
Alliance for Clinical Trials in Oncology 104
Not applicableLooking for participantsNCT06570824
What this trial is testing

RTMS as an Intervention for Levodopa-induced Dyskinesia

Who this might be right for
Dyskinesia, Drug-InducedParkinson Disease
Danish Research Centre for Magnetic Resonance 68
Large-scale testing (Phase 3)Study completedNCT00272051
What this trial is testing

XENOX - Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV Chemotherapy

Who this might be right for
MetastasesColorectal NeoplasmsColorectal Carcinoma
Sanofi 620
Not applicableStudy completedNCT00281853
What this trial is testing

Nerve Changes in Patients Who Are Undergoing Chemotherapy or Biological Therapy for Cancer

Who this might be right for
NeurotoxicityUnspecified Adult Solid Tumor, Protocol Specific
Case Comprehensive Cancer Center 15
Testing effectiveness (Phase 2)Study completedNCT00727831
What this trial is testing

Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma

Who this might be right for
Chemotherapeutic Agent ToxicityLymphomaMucositis+1 more
University College, London 4
Post-approval studies (Phase 4)Study completedNCT03877120
What this trial is testing

Treatment Of Alcohol Withdrawal Syndrome: Dexmedetomidine Vs Diazepam In A Hospital O'horán

Who this might be right for
Alcohol Withdrawal Delirium
Centro Medico Nacional La Raza, IMSS 2
Large-scale testing (Phase 3)Study completedNCT00046891
What this trial is testing

EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer

Who this might be right for
Breast CancerNeurotoxicity
Alliance for Clinical Trials in Oncology 226
Large-scale testing (Phase 3)Study completedNCT00068445
What this trial is testing

Lamotrigine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Who this might be right for
NeurotoxicityPainUnspecified Adult Solid Tumor, Protocol Specific
Alliance for Clinical Trials in Oncology 131
Not applicableStudy completedNCT00018967
What this trial is testing

Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate

Who this might be right for
NeurotoxicityUnspecified Adult Solid Tumor, Protocol SpecificUnspecified Childhood Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 10
Large-scale testing (Phase 3)Study completedNCT00471445
What this trial is testing

Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients

Who this might be right for
NeurotoxicityPainPeripheral Neuropathy+1 more
Gary Morrow 462
Not applicableStudy completedNCT04174469
What this trial is testing

Ivermectin Neurotoxicity and ABCB1 Gene Mutations

Who this might be right for
DNA Sequencing
University Hospital, Montpellier 3
Testing effectiveness (Phase 2)Study completedNCT00952848
What this trial is testing

Electrical Stimulation Therapy Using the MC5-A Scrambler in Reducing Peripheral Neuropathy Caused by Chemotherapy

Who this might be right for
Chemotherapeutic Agent ToxicityNeurotoxicityPain+2 more
Virginia Commonwealth University 18
Large-scale testing (Phase 3)Enrolling By InvitationNCT06950190
What this trial is testing

Evaluating Cognitive Changes on Patients in Chemotherapy (ECCPC)

Who this might be right for
Chemotherapy-related Cognitive Impairment
Ellis Medicine 100
Testing effectiveness (Phase 2)Study completedNCT01284855
What this trial is testing

Comparison of Two Dose Regimens of Snake Antivenom for the Treatment of Snake Bites Envenoming in Nepal

Who this might be right for
Snake Bite
CTU 250
Not applicableLooking for participantsNCT07767981
What this trial is testing

Microbiome Determinants of Adverse Effects of Stereotactic Radiosurgery

Who this might be right for
Adverse Radiation EffectsRadiation Necrosis
University of Chicago 150
Not applicableStudy completedNCT02412683
What this trial is testing

Neurotoxic Symptoms in Adjuvant Chemotherapy in Patients With Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Jenny Drott 50
Not applicableStudy completedNCT02055183
What this trial is testing

BT-010 Registry for the Evaluation of Safety and Clinical Outcomes in Patients Treated With Botulinum Antitoxin

Who this might be right for
Botulism
Emergent BioSolutions 162
Testing effectiveness (Phase 2)UnknownNCT06580236
What this trial is testing

Study of the Drug B11-FC (Botulism Treatment)

Who this might be right for
Botulism
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 40
Next Page